ATE159294T1 - Methoden und zusammensetzungen um die sensitivität eine zellegegen dna-zerstörende agentien zu erhöhen - Google Patents

Methoden und zusammensetzungen um die sensitivität eine zellegegen dna-zerstörende agentien zu erhöhen

Info

Publication number
ATE159294T1
ATE159294T1 AT93914044T AT93914044T ATE159294T1 AT E159294 T1 ATE159294 T1 AT E159294T1 AT 93914044 T AT93914044 T AT 93914044T AT 93914044 T AT93914044 T AT 93914044T AT E159294 T1 ATE159294 T1 AT E159294T1
Authority
AT
Austria
Prior art keywords
sensitivity
cell
compositions
methods
increase
Prior art date
Application number
AT93914044T
Other languages
English (en)
Inventor
Patricia S Steeg
Lance A Liotta
Ursula Flatow
Gilbert Chu
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE159294T1 publication Critical patent/ATE159294T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT93914044T 1992-05-20 1993-05-20 Methoden und zusammensetzungen um die sensitivität eine zellegegen dna-zerstörende agentien zu erhöhen ATE159294T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/886,368 US5770386A (en) 1992-05-20 1992-05-20 Methods and compositions for increasing the sensitivity of a cell to a DNA damaging agent

Publications (1)

Publication Number Publication Date
ATE159294T1 true ATE159294T1 (de) 1997-11-15

Family

ID=25388923

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93914044T ATE159294T1 (de) 1992-05-20 1993-05-20 Methoden und zusammensetzungen um die sensitivität eine zellegegen dna-zerstörende agentien zu erhöhen

Country Status (11)

Country Link
US (1) US5770386A (de)
EP (1) EP0642583B1 (de)
JP (1) JP3535513B2 (de)
AT (1) ATE159294T1 (de)
AU (1) AU677589B2 (de)
CA (1) CA2136094C (de)
DE (1) DE69314633T2 (de)
DK (1) DK0642583T3 (de)
ES (1) ES2110612T3 (de)
GR (1) GR3025500T3 (de)
WO (1) WO1993023546A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020102248A1 (en) * 2000-09-06 2002-08-01 The Government Of The United States Of America Modulating response to genotoxic stress
KR102548578B1 (ko) * 2020-06-29 2023-06-28 김홍렬 신규한 polyP 합성 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57138165A (en) * 1981-02-20 1982-08-26 Nec Corp Manufacture of semiconductor device
US5049662A (en) * 1987-10-13 1991-09-17 The United States Of America As Represented By The Department Of Health And Human Services Kit for diagnosing cancer metastatic potential
NL8802481A (nl) * 1988-10-10 1990-05-01 Texas Instruments Holland Transponder alsmede werkwijze voor het vervaardigen daarvan.
JPH02113533A (ja) * 1988-10-22 1990-04-25 Nec Corp 半導体装置
DE69033810T2 (de) * 1989-10-18 2002-03-28 The Government Of The United States Of America, As Represented By The Secretary National Institute Of Health Herstellung und verwendung des menschlichen nm23-h2-proteins und dagegen gerichtete antikörper
WO1991006671A1 (fr) * 1989-10-31 1991-05-16 Institut Pasteur Moyens pour la detection de cellules hautement proliferatives

Also Published As

Publication number Publication date
AU4385793A (en) 1993-12-13
ES2110612T3 (es) 1998-02-16
CA2136094A1 (en) 1993-11-25
DE69314633D1 (de) 1997-11-20
DK0642583T3 (da) 1998-03-30
GR3025500T3 (en) 1998-02-27
AU677589B2 (en) 1997-05-01
US5770386A (en) 1998-06-23
WO1993023546A1 (en) 1993-11-25
DE69314633T2 (de) 1998-02-19
JP3535513B2 (ja) 2004-06-07
CA2136094C (en) 2001-12-11
EP0642583A1 (de) 1995-03-15
EP0642583B1 (de) 1997-10-15
JPH08501205A (ja) 1996-02-13

Similar Documents

Publication Publication Date Title
ATE345682T1 (de) In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
JPS57500830A (de)
BG45701A3 (bg) Метод за получаване на алфа-хетероциклично заместени толунитрили
ATE59185T1 (de) Die antigenischen determinanten von hbxag.
DE69835010D1 (de) Feststellung von endometriumkrebs
DE2960533D1 (en) Method for the quantitative enzymatic determination of adp and reagent for this method
Borman et al. Mentoring: An effective career guidance technique.
BG35465A3 (en) Method for preparing derivatives of 1-(cyclohexyl)-4-aryl-4- piperidine carbonic acid
IT8167698A0 (it) Cella elettrochimica particolarmente per l analisi elettrochimica di gas e procedimento per la sua fabbricazione
IL81695A (en) Quantitative determination of the degree of amplification of genes and/or corresponding messenger rna and reagent kit for performing the determination
DK155053C (da) Bainithaerdelig, transformationstraeg staallegering med hoej styrke samt fremgangsmaade til fremstilling heraf
IT8123630A0 (it) Procedimento e agente per passivare superfici di ferro e di acciaio.
DE3585731D1 (de) Dram-zelle und verfahren.
ATE227996T1 (de) Zusammensetzung und verfahren zur regulierung von zellproliferation und zelltod
DE3585136D1 (de) Dram-zelle und verfahren.
ATE159294T1 (de) Methoden und zusammensetzungen um die sensitivität eine zellegegen dna-zerstörende agentien zu erhöhen
IT8419730A0 (it) Procedimento per la trasformazione quantitativa di teicoplanina a2fattore 1 in teicoplanina a2fattore 3.
Ascoli Inhibition of the degradation of receptor-bound human choriogonadotropin by leupeptin
DE3582608D1 (de) Verfahren und zell-linie zum erhalten von plasminogen-aktivatoren.
ATE11930T1 (de) In vitro verfahren zum bestimmen von krebs im saeugergewebe.
ES2187668T3 (es) Formulacion de oxido de 1,2,4-benzotriazina en capsulas de gel oral es.
IT1212697B (it) Strumento per la discesa in un foro di scavo e metodo per la fabbricazione e l'impiego di esso.
GB2060646B (en) Method for determining the activity of the angiotensin-converting enzyme and substrate and compositions for use therein
IT7969143A0 (it) Agente inoculante e procedimento per inoculazione di ghise fuse
GB1303456A (de)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee